Literature DB >> 17079452

p16INK4a modulates p53 in primary human mammary epithelial cells.

Jianmin Zhang1, Curtis R Pickering, Charles R Holst, Mona L Gauthier, Thea D Tlsty.   

Abstract

p16(INK4a) (p16) and p53 are tumor suppressor genes that are inactivated during carcinogenesis in many tumors. Here we show that p16 gene activity inversely modulates p53 status and function in primary human mammary epithelial cells. Reduced levels of p16 protein stabilize p53 protein through inhibition of proteolytic degradation, and this increase in p53 protein levels enhances the cellular response to radiation, represses proliferation, and transcriptionally activates downstream targets. Stabilization of p53 is mediated through the retinoblastoma/E2F/p14(ARF)/murine double minute-2 pathway. However, we have observed that p16 does not modulate p53 in fibroblasts, indicating a possible cell type-specific regulation of this pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17079452     DOI: 10.1158/0008-5472.CAN-06-1594

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  24 in total

Review 1.  Aging, cellular senescence, and cancer.

Authors:  Judith Campisi
Journal:  Annu Rev Physiol       Date:  2012-11-08       Impact factor: 19.318

2.  Overexpressions of Cyclin B1, cdc2, p16 and p53 in human breast cancer: the clinicopathologic correlations and prognostic implications.

Authors:  Seoung Wan Chae; Jin Hee Sohn; Dong-Hoon Kim; Yoon Jung Choi; Yong Lai Park; Kyungeun Kim; Young Hye Cho; Jung-Soo Pyo; Jun Ho Kim
Journal:  Yonsei Med J       Date:  2011-05       Impact factor: 2.759

3.  Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors.

Authors:  Mona L Gauthier; Hal K Berman; Caroline Miller; Krystyna Kozakeiwicz; Karen Chew; Dan Moore; Joseph Rabban; Yunn Yi Chen; Karla Kerlikowske; Thea D Tlsty
Journal:  Cancer Cell       Date:  2007-11       Impact factor: 31.743

4.  Molecular distinctions between stasis and telomere attrition senescence barriers shown by long-term culture of normal human mammary epithelial cells.

Authors:  James C Garbe; Sanchita Bhattacharya; Batul Merchant; Ekaterina Bassett; Karen Swisshelm; Heidi S Feiler; Andrew J Wyrobek; Martha R Stampfer
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

Review 5.  When mutants gain new powers: news from the mutant p53 field.

Authors:  Ran Brosh; Varda Rotter
Journal:  Nat Rev Cancer       Date:  2009-08-20       Impact factor: 60.716

6.  The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss.

Authors:  Tamara Terzian; Young-Ah Suh; Tomoo Iwakuma; Sean M Post; Manja Neumann; Gene A Lang; Carolyn S Van Pelt; Guillermina Lozano
Journal:  Genes Dev       Date:  2008-05-15       Impact factor: 11.361

7.  Dissecting cellular responses to irradiation via targeted disruptions of the ATM-CHK1-PP2A circuit.

Authors:  Stela S Palii; Yuxia Cui; Cynthia L Innes; Richard S Paules
Journal:  Cell Cycle       Date:  2013-03-05       Impact factor: 4.534

Review 8.  Diverse roles of miR-335 in development and progression of cancers.

Authors:  Long-Ji Luo; Dan-Dan Wang; Jing Wang; Fan Yang; Jin-Hai Tang
Journal:  Tumour Biol       Date:  2016-10-08

Review 9.  The rebel angel: mutant p53 as the driving oncogene in breast cancer.

Authors:  Dawid Walerych; Marco Napoli; Licio Collavin; Giannino Del Sal
Journal:  Carcinogenesis       Date:  2012-07-20       Impact factor: 4.944

10.  Cell-type specific DNA methylation patterns define human breast cellular identity.

Authors:  Petr Novak; Martha R Stampfer; Jose L Munoz-Rodriguez; James C Garbe; Mathias Ehrich; Bernard W Futscher; Taylor J Jensen
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.